Abstract
HEREDITARY DEMYELINATING NEUROPATHIES IN THE DEVELOPING WORLD At the Hospital das Clinicas, Faculty of Medicine of Ribeirão Preto, University of São Paulo we have categorized so far 1319 CMT1/CMT4 patients. At the beginning of our activities (1997), those patients suspected of having CMT were submitted to nerve conductions studies and those with upper limbs CV < 38 m/s or having intermediate values were initially submitted to the PMP22 duplication/deletion test. Gradually, we introduced PMP22, MPZ and GJB1 Sanger sequencing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
